Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan

BACKGROUND: Few studies have investigated treatment options for patients with Alzheimer's disease (AD) showing a poor response to oral cholinesterase inhibitors (ChEIs) in Japan. OBJECTIVE: To investigate the efficacy and safety of switching from oral ChEIs to rivastigmine transdermal patch in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Kengo, Katayama, Sadao, Arai, Tetsuaki, Furuta, Nobuo, Ikebe, Shinichiro, Ishida, Yoshinori, Kanaya, Kiyoshi, Ouma, Shinji, Sakurai, Hirofumi, Sugitani, Masato, Takahashi, Makio, Tanaka, Toshihisa, Tsuno, Norifumi, Wakutani, Yosuke, Shekhawat, Ankita, Das Gupta, Ayan, Kiyose, Kazuki, Toriyama, Kazuhiro, Nakamura, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751467/
https://www.ncbi.nlm.nih.gov/pubmed/31572426
http://dx.doi.org/10.1159/000501364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751467/
https://www.ncbi.nlm.nih.gov/pubmed/31572426
http://dx.doi.org/10.1159/000501364

Ejemplares similares